CD8A and neoplasm: Results: Although the vaccines with a high number of peptides, i.e., 100–200 peptides/RNA-OG, led to greater peptide presentation by bone marrow-derived dendritic cells, they failed to mount effective CD8+ T cell responses against engrafted tumor cells, probably owing to an induction of early T cell exhaustion.